These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23441089)

  • 21. Thrombocytosis.
    Skoda RC
    Hematology Am Soc Hematol Educ Program; 2009; ():159-67. PubMed ID: 20008195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translocation t(1;9) is a recurrent cytogenetic abnormality associated with progression of essential thrombocythemia patients displaying the JAK2 V617F mutation.
    Leon A; Staropoli JF; Hernandez JM; Longtine JA; Kuo FC; Dal Cin P
    Leuk Res; 2011 Sep; 35(9):1188-92. PubMed ID: 21376394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombopoietin Measurement as a Key Component in the Evaluation of Pediatric Thrombocytosis.
    Nelson ND; Marcogliese A; Bergstrom K; Scheurer M; Mahoney D; Bertuch AA
    Pediatr Blood Cancer; 2016 Aug; 63(8):1484-7. PubMed ID: 27100794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic study of the impact of the JAK2-V617F mutation on the phenotype of essential thrombocythemia.
    Mossuz P; Arlotto M; Hermouet S; Bouamrani A; Lippert E; Girodon F; Dobo I; Vincent P; Cahn JY; Berger F
    Exp Hematol; 2008 Dec; 36(12):1642-7. PubMed ID: 18838204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort.
    Randi ML; Geranio G; Bertozzi I; Micalizzi C; Ramenghi U; Tucci F; Notarangelo LD; Ladogana S; Menna G; Giordano P; Consarino C; Farruggia P; Zanazzo GA; Fiori GM; Burnelli R; Russo G; Jankovich M; Peroni E; Duner E; Basso G; Fabris F; Putti MC
    Br J Haematol; 2015 May; 169(4):584-9. PubMed ID: 25716342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation status of essential thrombocythemia and primary myelofibrosis defines clinical outcome.
    Asp J; Andréasson B; Hansson U; Wasslavik C; Abelsson J; Johansson P; Palmqvist L
    Haematologica; 2016 Apr; 101(4):e129-32. PubMed ID: 26768689
    [No Abstract]   [Full Text] [Related]  

  • 27. JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science.
    Kilpivaara O; Levine RL
    Leukemia; 2008 Oct; 22(10):1813-7. PubMed ID: 18754026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation.
    Szpurka H; Gondek LP; Mohan SR; Hsi ED; Theil KS; Maciejewski JP
    Leukemia; 2009 Mar; 23(3):610-4. PubMed ID: 18818701
    [No Abstract]   [Full Text] [Related]  

  • 29. Familial essential thrombocythemia with spontaneous megakaryocyte colony formation and acquired JAK2 mutations.
    Higgs JR; Sadek I; Neumann PE; Ing VW; Renault NK; Berman JN; Greer WL
    Leukemia; 2008 Aug; 22(8):1551-6. PubMed ID: 18496561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617F.
    Gibson SE; Schade AE; Szpurka H; Bak B; Maciejewski JP; Hsi ED
    Hum Pathol; 2008 Jul; 39(7):1111-4. PubMed ID: 18479730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MPL exon 10 mutations other than canonical MPL W515L/K mutations identified by in-house MPL exon 10 direct sequencing in essential thrombocythemia.
    Sugimoto Y; Nagaharu K; Ohishi K; Nakamura M; Ikejiri M; Nakatani K; Mizutani M; Tamaki S; Ikeda T; Tawara I; Katayama N
    Int J Hematol; 2021 May; 113(5):618-621. PubMed ID: 33770389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity.
    Ding J; Komatsu H; Iida S; Yano H; Kusumoto S; Inagaki A; Mori F; Ri M; Ito A; Wakita A; Ishida T; Nitta M; Ueda R
    Blood; 2009 Oct; 114(15):3325-8. PubMed ID: 19483125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia.
    Vannucchi AM; Antonioli E; Guglielmelli P; Pancrazzi A; Guerini V; Barosi G; Ruggeri M; Specchia G; Lo-Coco F; Delaini F; Villani L; Finotto S; Ammatuna E; Alterini R; Carrai V; Capaccioli G; Di Lollo S; Liso V; Rambaldi A; Bosi A; Barbui T
    Blood; 2008 Aug; 112(3):844-7. PubMed ID: 18519816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JAK2 V617F-positive essential thrombocythemia in a patient with Klinefelter syndrome: a case report.
    Yhim HY; Kim HS; Sohn JY; Song MJ; Lee NR; Song EK; Choi SI; Yim CY; Kwak JY
    Cancer Genet Cytogenet; 2010 Apr; 198(2):162-5. PubMed ID: 20362232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of putative noncanonical driver mutations in patients with essential thrombocythemia.
    Arai A; Yoshimitsu M; Otsuka M; Ito Y; Miyazono T; Nakano N; Obama K; Nakashima H; Hanada S; Owatari S; Nakamura D; Tokunaga M; Kamada Y; Utsunomiya A; Haraguchi K; Hayashida M; Fujino S; Odawara J; Tabuchi T; Suzuki S; Hamada H; Kawamoto Y; Uchida Y; Hachiman M; Ishitsuka K
    Eur J Haematol; 2023 Jun; 110(6):639-647. PubMed ID: 36811253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous regression of essential thrombocythemia with MPL mutation on menopause.
    Otsuka M; Hanada S; Arita K; Ohashi H
    Int J Hematol; 2014; 99(5):668-70. PubMed ID: 24609764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of MPL mutations by a novel allele-specific PCR-based strategy.
    Furtado LV; Weigelin HC; Elenitoba-Johnson KS; Betz BL
    J Mol Diagn; 2013 Nov; 15(6):810-8. PubMed ID: 23994117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.
    Gangat N; Wassie EA; Lasho TL; Finke C; Ketterling RP; Hanson CA; Pardanani A; Wolanskyj AP; Maffioli M; Casalone R; Passamonti F; Tefferi A
    Eur J Haematol; 2015 Jan; 94(1):31-6. PubMed ID: 24889737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The analysis of JAK2 and MPL mutations and JAK2 single nucleotide polymorphisms in MPN patients by MassARRAY assay.
    Zhang SJ; Qiu HX; Li JY; Shi JY; Xu W
    Int J Lab Hematol; 2010 Aug; 32(4):381-6. PubMed ID: 20331763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro, with rare JAK2 V617F-positive erythroid colonies.
    Veselovska J; Pospisilova D; Pekova S; Horvathova M; Solna R; Cmejlova J; Cmejla R; Belickova M; Mihal V; Stary J; Divoky V
    Leuk Res; 2008 Mar; 32(3):369-77. PubMed ID: 17719087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.